Covenant Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Covenant Asset Management's BIIB Position: Q4 2021 in Review
Covenant Asset Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 794 shares — an estimated $225K sold.
Covenant Asset Management first reported a position in BIIB in Q4 2016 and held it in 19 quarters. The position peaked at $3.64M in Q4 2016. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.
- Covenant Asset Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
- Covenant Asset Management sold 794 Biogen shares in Q4 2021, an estimated $225K.
- Covenant Asset Management first reported a position in Biogen in Q4 2016 and held it in 19 quarters.
- Covenant Asset Management's Biogen position peaked at $3.64M in Q4 2016.
- 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.
Based on Covenant Asset Management's 13F filing for Q4 2021, filed 26 Jan 2022.